Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBITDA (2016 - 2025)

Alkermes (ALKS) has disclosed EBITDA for 16 consecutive years, with $48.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA fell 66.48% to $48.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $241.5 million, a 34.4% decrease, with the full-year FY2025 number at $241.5 million, down 34.4% from a year prior.
  • EBITDA was $48.3 million for Q4 2025 at Alkermes, down from $83.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $237.8 million in Q2 2023 to a low of -$66.3 million in Q3 2022.
  • A 5-year average of $37.9 million and a median of $29.7 million in 2024 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: crashed 6840.9% in 2022, then surged 834.04% in 2023.
  • Alkermes' EBITDA stood at -$379000.0 in 2021, then plummeted by 6840.9% to -$26.3 million in 2022, then skyrocketed by 539.99% to $115.7 million in 2023, then grew by 24.51% to $144.1 million in 2024, then tumbled by 66.48% to $48.3 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's EBITDA are $48.3 million (Q4 2025), $83.1 million (Q3 2025), and $87.2 million (Q2 2025).